Office of Biotechnology Activities    National Institutes of Health - Office of Science Policy   RAC June 8, 2004 - Presentation Materials 96th Meeting Day 1 Bethesda, Maryland Update on Protocol 0107- 488     A Phase I, Open-Label Clinical Trial of the Safety and Tolerability of Single Escalating Doses of Autologous CD4 T Cells Transduced with VRX496 in HIV-Positive Subjects (In-depth review and public discussion at the September 2001 RAC meeting)     Boro Dropulic, Ph.D., VIRxSYS Corporation, Gaithersburg, MD     Webcast Slides     Discussion of Human Gene Transfer Protocol #0404-642     A Phase I Trial of Gene Transfer during VAD Support with SERCA2a     Barry London, M.D., Ph.D., University of Pittsburgh Medical Center     Webcast Slides     Introduction to Upcoming Safety Symposium     Safety Considerations in Recombinant DNA Research with Highly Pathogenic Viruses     Kanta Subbarao, M.D., M.P.H., Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH Christina Cassetti, Ph.D., Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH     Webcast Slides set 1 Slides set 2 Slides set 3     Discussion of Human Gene Transfer Protocol #0403-633     A Phase I Trial of Immunotherapy with BHT-3009 Alone or Combined with Atorvastatin in Patients with Multiple Sclerosis     Timothy L. Vollmer, MD, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center     Webcast Slides set 1 Slides set 2     Discussion of Human Gene Transfer Protocol #0404-641     A Phase I, Open-Label, Nonrandomized, Dose-Escalation, Multicenter Therapeutic Trial of the Safety, Immunogenicity and Efficacy of GI-4000, an Inactivated Recombinant Saccharomyces cerevisiae Immunotherapeutic Expressing Three Different Mutations of the Ras Oncoprotein, in Patients with Solid Tumors Expressing Mutations in Ras     Bert O'Neil, M.D., University of North Carolina School of Medicine, Chapel Hill, NC     Webcast Slides     Update on the RAC Gene Transfer Clinical Trial Design Working Group     David DeMets, Ph.D., NIH RAC     Webcast     ADJOURN     Top of Page

6705 Rockledge Drive, Suite 750, MSC 7985 Bethesda, MD 20892-7985 (For all non-USPS mail, please use ZIP code 20817) Phone: 301-496-9838, Fax: 301-496-9839 E-mail OBA at oba@od.nih.gov

RDNA312